Literature DB >> 2989487

Differences in responsiveness of intrapulmonary artery and vein to arachidonic acid: mechanism of arterial relaxation involves cyclic guanosine 3':5'-monophosphate and cyclic adenosine 3':5'-monophosphate.

L J Ignarro, R G Harbison, K S Wood, M S Wolin, D B McNamara, A L Hyman, P J Kadowitz.   

Abstract

The objective of this study was to examine the relationship between responses of bovine intrapulmonary artery and vein to arachidonic acid and cyclic nucleotide levels in order to better understand the mechanism of relaxation elicited by arachidonic acid and acetylcholine. Arachidonic acid relaxed phenylephrine-precontracted arterial rings and elevated both cyclic GMP and cyclic AMP levels in arteries with intact endothelium. In contrast, endothelium-damaged arterial rings contracted to arachidonic acid without demonstrating significant changes in cyclic nucleotide levels. Indomethacin partially inhibited endothelium-dependent relaxation and abolished cyclic AMP accumulation whereas methylene blue, a guanylate cyclase inhibitor, partially inhibited relaxation and abolished cyclic GMP accumulation in response to arachidonic acid. All vessel responses were blocked by a combination of the two inhibitors. Prostaglandin (PG) I2 relaxed arterial rings and elevated cyclic AMP levels whereas PGE2 and PGF2 alpha caused contraction, suggesting that the indomethacin-sensitive component of arachidonic acid-elicited relaxation is due to PGI2 formation and cyclic AMP accumulation. The methylene blue-sensitive component is attributed to an endothelium-dependent but cyclooxygenase-independent generation of a substance causing cyclic GMP accumulation. Intrapulmonary veins contracted to arachidonic acid with no changes in cyclic nucleotide levels and PGI2 was without effect. Homogenates of intrapulmonary artery and vein formed 6-keto-PGF1 alpha, PGF2 alpha and PGE2 from [14C]arachidonic acid, which was inhibited by indomethacin. Thus, bovine intrapulmonary vein may not possess receptors for PGI2. The failure of endothelium-intact vein to relax to acetylcholine may be related to the lack of a relaxant effect by arachidonic acid, perhaps attributed to the absence of generation of an endothelium-derived relaxing factor.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2989487

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  10 in total

1.  Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide.

Authors:  L J Ignarro; G M Buga; K S Wood; R E Byrns; G Chaudhuri
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

Review 2.  Heme Oxygenases in Cardiovascular Health and Disease.

Authors:  Anita Ayer; Abolfazl Zarjou; Anupam Agarwal; Roland Stocker
Journal:  Physiol Rev       Date:  2016-10       Impact factor: 37.312

3.  Endothelium-dependent relaxation is independent of arachidonic acid release.

Authors:  P G Milner; N J Izzo; J Saye; A L Loeb; R A Johns; M J Peach
Journal:  J Clin Invest       Date:  1988-06       Impact factor: 14.808

4.  Acidosis potentiates endothelium-dependent vasorelaxation and gap junction communication in the superior mesenteric artery.

Authors:  Ipsita Mohanty; Subas Chandra Parija; Sujit Suklabaidya; Satish Rattan
Journal:  Eur J Pharmacol       Date:  2018-03-07       Impact factor: 4.432

5.  Acetylcholine-induced K+ currents in smooth muscle cells of intact rat small arteries.

Authors:  T Weidelt; W Boldt; F Markwardt
Journal:  J Physiol       Date:  1997-05-01       Impact factor: 5.182

6.  History of right heart catheterization: 100 years of experimentation and methodology development.

Authors:  Bobby D Nossaman; Brittni A Scruggs; Vaughn E Nossaman; Subramanyam N Murthy; Philip J Kadowitz
Journal:  Cardiol Rev       Date:  2010 Mar-Apr       Impact factor: 2.644

7.  Actions of SQ 29,548 on contractile responses and arachidonic acid metabolism of intrapulmonary arteries, in vitro.

Authors:  V L Boyd; P Kvamme; R Harbison; P J Kadowitz; D B McNamara
Journal:  Agents Actions       Date:  1992-03

8.  High-affinity binding of [3H]cimetidine to a heme-containing protein in rat brain.

Authors:  Rebecca Stadel; Jun Yang; Julia W Nalwalk; James G Phillips; Lindsay B Hough
Journal:  Drug Metab Dispos       Date:  2007-12-19       Impact factor: 3.922

9.  Prostacyclin release and receptor activation: differential control of human pulmonary venous and arterial tone.

Authors:  Xavier Norel; Laurence Walch; Jean-Pierre Gascard; Vincent deMontpreville; Charles Brink
Journal:  Br J Pharmacol       Date:  2004-06-01       Impact factor: 8.739

10.  Inhibitory action of alpha-human atrial natriuretic peptide on noradrenaline-induced synthesis of myo-inositol 1,4,5-trisphosphate in the smooth muscle cells of rabbit aorta.

Authors:  J Kajikuri; H Kuriyama
Journal:  Br J Pharmacol       Date:  1990-03       Impact factor: 8.739

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.